SEC Form 4 · accession 0001225208-15-020267
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael F Mahoney
Officer — President & CEO · Director
Period of report
Nov 1, 2015
Accepted (ET)
Nov 3, 2015 · 4:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 1, 2015 | M | 341,669 | $0.00 | A | 1,596,252 | D | |
| Common Stock | Nov 1, 2015 | F | 160,927 | $18.28 | D | 1,435,325 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Deferred Stock UnitsF1,F2 | $0.00 | Nov 1, 2015 | M | 341,669 | D | — | — | Common Stock | 341,669 | 341,670 | D |
Explanation of responses
- F1Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- F2The award vests in five equal installments beginning on November 1, 2012, the first anniversary of the date of grant.